Edition:
United States

Viking Therapeutics Inc (VKTX.OQ)

VKTX.OQ on NASDAQ Stock Exchange Capital Market

9.81USD
3:59pm EST
Change (% chg)

$0.33 (+3.48%)
Prev Close
$9.48
Open
$9.74
Day's High
$10.26
Day's Low
$9.58
Volume
845,587
Avg. Vol
1,055,758
52-wk High
$24.00
52-wk Low
$3.66

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Lawson Macartney

60 2015 independent Chairman of the Board

Brian Lian

52 2015 President, Chief Executive Officer, Director

Michael Morneau

52 2014 Chief Financial Officer

Matthew Foehr

45 2014 Director

Charles Rowland

59 2017 Independent Director